Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 42INDUSTRY 3FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Renal Insufficiency, Chronic 1Renal Artery Obstruction 1Pulmonary Embolism 1Lung Neoplasms 1

Interventions

Exercise 6pembrolizumab 5enzalutamide 4Docetaxel 4Colonoscopy 4Celecoxib 4sargramostim 3apalutamide 3Prednisone 3Methods 3Leuprolide 3Itraconazole 3Imiquimod 3Granulocyte-Macrophage Colony-Stimulating Factor 3Golytely 3Cryotherapy 3Abiraterone Acetate 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3abiraterone 2Yoga 2Topotecan 2Testosterone 2Tablets 2Simvastatin 2Radiosurgery 2Palliative Care 2Midazolam 2Gelatin 2Decision Support Techniques 2Collagenases 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Interventional × Acetylcysteine × Clear all
NCT02476526 2017-11-28

Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease

VA Greater Los Angeles Healthcare System

Phase 4 Completed
50 enrolled
Thoracic

Lung Neoplasms, Pulmonary Embolism, Renal Artery Obstruction, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡